key: cord-0920556-9zg8q0gk authors: Zhang, Jiancheng; Xu, Dan; Xie, Bing; Zhang, Yujing; Huang, Haiyan; Liu, Hongmei; Chen, Huaqi; Sun, Yongbo; Shang, You; Hashimoto, Kenji; Yuan, Shiying title: Poor-sleep is associated with slow recovery from lymphopenia and an increased need for ICU care in hospitalized patients with COVID-19: A retrospective cohort study date: 2020-06-06 journal: Brain Behav Immun DOI: 10.1016/j.bbi.2020.05.075 sha: df99f9c1da4ba098b9d6a493d003713b4f7e1355 doc_id: 920556 cord_uid: 9zg8q0gk Sleep is known to play an important role in immune function. However, the effects of sleep quality during hospitalization for COVID-19 remain unclear. This retrospective, single-center cohort study was conducted to investigate the effects of sleep quality on recovery from lymphopenia and clinical outcomes in hospitalized patients with laboratory-confirmed COVID-19 admitted to the West District of Wuhan Union Hospital between January 25 and March 15, 2020. The Richards-Campbell sleep questionnaire (RCSQ) and Pittsburgh Sleep Quality Index (PSQI) were used to assess sleep quality. The epidemiological, demographic, clinical, laboratory, treatment, and outcome data were collected from electronic medical records and compared between the good-sleep group and poor-sleep group. In all, 135 patients (60 in good-sleep group and 75 in poor-sleep group) were included in this study. There were no significant between-group differences regarding demographic and baseline characteristics, as well as laboratory parameters upon admission and in-hospital treatment. Compared with patients in the good-sleep group, patients in the poor-sleep group had lower absolute lymphocyte count (ALC) (day 14: median, 1.10 vs 1.32, P = 0.0055; day 21: median, 1.18 vs 1.48, P = 0.0034) and its reduced recovery rate (day 14: median, 56.91 vs 69.40, P = 0.0255; day 21: median, 61.40 vs 111.47, P = 0.0003), as well as increased neutrophil-to-lymphocyte ratio (NLR; day 14: median, 3.17 vs 2.44, P = 0.0284; day 21: median, 2.73 vs 2.23, P = 0.0092) and its associated deterioration rate (day 14: median, -39.65 vs -61.09, P = 0.0155; day 21: median, -51.40% vs -75.43, P = 0.0003). Nine [12.0%] patients in the poor-sleep group required ICU care (P = 0.0151); meanwhile, none of the patients in good-sleep group required ICU care. Patients in the poor-sleep group had increased duration of hospital stay (33.0 [23.0–47.0] days vs 25.0 [20.5–36.5] days, P = 0.0116) compared to those in the good-sleep group. An increased incidence of hospital-acquired infection (seven [9.3%] vs one [1.7%]) was observed in the poor-sleep group compared to the good-sleep group; however, this difference was not significant (P = 0.1316). In conclusion, poor sleep quality during hospitalization in COVID-19 patients with lymphopenia is associated with a slow recovery from lymphopenia and an increased need for ICU care. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has rapidly spread worldwide. COVID-19 is highly contagious and can result in acute respiratory distress, multiple organ failure, or death in severe cases (Huang et al., 2020a; Wang et al., 2020; Yang et al., 2020; Zhang et al., 2020) . The reported mortality rate of COVID-19 is lower than that of severe acute respiratory syndrome (SARS) (Donnelly et al., 2003) , or Middle East respiratory syndrome (MERS) (Ahmed, 2017) . However, the number of patients needing urgent critical care is remarkably larger than previous outbreaks of SARS or MERS, which could lead to a critical shortage of intensive care unit (ICU) beds and specialized medical and nursing personnel, and, consequently, result in the collapse of local health care systems. Thus, timely and appropriate dynamic monitoring and treatment for non-ICU inpatients is urgent and necessary to reduce the risk of patients becoming critically ill and requiring ICU care. Patients with COVID-19 typically present a decrease in absolute lymphocyte count (ALC) (Huang et al., 2020a; Wang et al., 2020) . The dynamic profile of total circulating lymphocytes indicated that a continuous and sustained decrease in the ALC is closely associated with disease aggravation and death in COVID-19 patients Zhou et al., 2020) . Indeed, lymphopenia was associated with increased disease severity in COVID-19 (Tan et al., 2020) . In addition, the neutrophil-to-lymphocyte ratio (NLR) can also serve as a simple complementary indicator to predict clinical severity and prognosis, and is 6 an independent risk factor for mortality in patients with COVID-19 (Lagunas-Rangel, 2020; Qin et al., 2020; Liu et al., 2020) . These studies indicate that promoting recovery from lymphopenia and slowing the deterioration based on an increased NLR may reduce the need for ICU care and improve the prognosis of patients with COVID-19. To date, no specific drugs have been shown to be effective in alleviating lymphopenia in patients with COVID-19. Sleep is a physiological and behavioral process required for survival and plays an important role in metabolism and immune system homeostasis (Besedovsky et al., 2019; Haspel et al., 2020; Mukherjee et al., 2015) ; indeed, sleep and immunity are bidirectionally linked (Besedovsky et al., 2019) . Sleep disturbance impairs innate and adaptive immune responses and activates inflammation, with an increase in circulating inflammatory cytokines due to disruption of the circadian rhythms (Haack et al., 2007; Irwin, 2015; Vgontzas et al., 2004 ). Short-term sleep deprivation is associated with compromised natural killer cell activity in the blood (Fondell et al., 2011) . Disruption of the circadian rhythm of sleep, shorter sleep duration, or poor quality of sleep could increase susceptibility to upper respiratory infections (Cohen et al., 2009; Loef et al., 2019; Patel et al., 2012; Prather et al., 2015) . In fact, septic patients with frequently disrupted sleep have higher mortality rates (Huang et al., 2014) . Sleep impairment occurs frequent in patients with COVID-19 (Liguori et al., 2020) , which may be due to isolated environment without family member' companion, physical discomfort caused by the illness, or psychological factor (fear, anxiety, helplessness and/or depression, etc.) (Guo et al., 2020) . However, there are currently no reports of the effects of sleep quality during hospitalization on immune function 7 recovery and prognosis in patients with COVID-19. In tour study, we aimed to describe the effects of self-reported sleep quality on recovery from lymphopenia, deterioration based on an increased NLR, and clinical outcomes in hospitalized patients with COVID-19. 8 For this single-center retrospective study, 449 hospitalized patients with laboratory confirmed COVID-19 admitted to the West District of Wuhan Union Hospital between January 25 and March 15, 2020 were screened using the following inclusion and exclusion criteria. The inclusion criteria included: (1) patients aged between 18 and 80 years; and (2) absolute counts of peripheral blood lymphocytes <1.1 × 10 9 /L within 24 hours of hospital admission. The exclusion criteria included: (1) duration of hospital stay <14 days or death during hospitalization; (2) pregnant or lactating women; (3) deterioration of the condition requiring ICU care within 14 days of admission; and (4) loss of consciousness during hospitalization. A total of 153 patients met these criteria and were included in the study (Fig. 1) We reviewed the hospital's electronic medical records, nurse records, laboratory findings, and imaging examinations for all patients with confirmed COVID-19. All data were checked by two researchers. We collected data on age, sex, body mass index, education levels, marital status, comorbidities (chronic respiratory disease, cardiovascular and cerebrovascular diseases, and gastrointestinal, endocrine, urologic, and nervous system diseases), current smoking status, time from symptom onset to admission, signs and symptoms at disease onset, chest imaging abnormalities (unilateral or bilateral distribution of patchy shadows or ground glass opacity), vital signs on admission (respiratory rate, percutaneous oxygen saturation, heart rate, systolic blood pressure, and body temperature), laboratory parameters within 24 hours of admission (blood routine, blood biochemistry and electrolytes, cardiac biomarkers, and coagulation parameters), treatment (oxygen therapy, vasoconstrictive agents, antiviral therapy, antibiotics, corticosteroids, immunoglobulin, and immunoregulatory therapy), and complications during hospitalization (acute kidney injury (AKI), acute liver dysfunction, acute cardiac injury, hyperglycemia, and hospital-acquired infection (HAI)). AKI was identified based on the definition in the Kidney Disease: Improving Global Outcomes statement (KDIGO, 2012). Cardiac injury was diagnosed when the levels of serum hypersensitive cardiac troponin I exceeded the upper limit of normal (ULN), measured in the laboratory of the Wuhan Union Hospital. Acute liver dysfunction was defined as an ALT ≥1× ULN. HAI was defined as infection acquired more than 48 hours after hospital admission. For patient(s) with deterioration of the condition requiring ICU care, the subsequent data regarding laboratory parameters, treatment, and complications were not included in the final analysis. The Richards-Campbell sleep questionnaire (RCSQ), a widely used subjective survey instrument (Nagatomo et al., 2020; Richards et al., 2000; Simons et al., 2018) , was administered to assess sleep quality. Sleep assessment was performed by telephone within 30 days after hospital admission. The overall sleep quality was assessed within the first week (score one), second week (score two), and third week (score three) after admission using the RCSQ, since not all patients were able to accurately assess their daily sleep quality. The RCSQ assesses the following five items on a 0-100 mm visual analog scale: perceived sleep depth, sleep latency, frequency of awakenings, latency after awakenings, and sleep quality. The overall RCSQ score is the average value of these five items, with higher scores indicating better sleep quality. Self-reported factors associated with disruptive sleep were also recorded. After assessment with the RCSQ, sleep quality within two or three weeks after hospital admission was further confirmed using the Chinese version of the Pittsburgh Sleep Quality Index (PSQI), which is reliable and valid for the Chinese population (Liu et al., 1996) . The PSQI includes seven component scores: subjective sleep quality, sleep duration, sleep latency, habitual sleep efficiency, sleep disturbances, use of sleep medication, and daytime dysfunction. The sum of the seven component scores (each ranging from 0 to 3) provides the global sleep quality score (ranging from 0 to 21), with a score greater than 7 indicating poor sleep quality (Liu et al., 1996) . Patients were divided into two groups: good-sleep group (at least two RCSQ scores ≥70, and PSQI ≤7) and poor-sleep group (at least two RCSQ scores ≤50, and PSQI >7). Patients with deterioration of their health condition requiring ICU care, or those with a duration of hospital stay <21 days were assigned to one of the two groups based on the overall quality of their sleep within the first two weeks after hospital admission: patients with two RCSQ scores ≥70 and PSQI ≤7 were assigned to the good-sleep group and those with one RCSQ score ≤50 and PSQI >7 were assigned to the poor-sleep group. The primary outcomes were: (1) recovery rate based on ALC and deterioration based on an increased NLR on day 7, 14, and 21 after admission; (2) need for ICU care within 14 days of hospital admission. The absolute counts of peripheral blood lymphocytes and neutrophils within 24 hours of hospital admission were set as baseline value. The formula for the recovery percentage or deteriorative percentage is described as: The secondary outcomes were: (1) HAI; and (2) total length of hospital stay. Categorical variables were described as number (%). Continuous variables were described using mean (SD) if they were normally distributed, or median (interquartile range, IQR) if they were not. Continuous variables were compared using independent group t tests when the data were normally distributed; otherwise, the Mann-Whitney test was used. Proportions for categorical variables were compared using the χ 2 test, Yates' continuity corrected χ 2 test, or Fisher's exact test. A two-sided P value <0.05 was considered statistically significant. The data collected were all analyzed using SPSS version 20.0 software (SPSS, Tokyo, Japan). In Therefore, we included 135 patients (60 in the good-sleep group and 75 in the poor-sleep group) in the final analysis ( Fig. 1 ). The median age of patients was 63 years (IQR, 55-69 years), and 57.8% of patients were men (Table 1 ). The median interval time from symptom onset to admission was 11.0 days (IQR, 9.0-13.5 days). A total of 83 (61.5%) patients had comorbidities, and 134 (99.3%) patients had bilateral distribution of patchy shadows or ground glass opacity on chest x-ray or CT imaging. There were no significant between-group differences in demographic and 14 baseline characteristics (Table 1) , as well as laboratory parameters upon hospital admission and treatment during hospitalization (Table 3) . Patients in the poor-sleep group had lower RCSQ scores in the first week ( 60.0%, 56.0%, and 32.0% of patients, respectively (Table 2) . During hospitalization, there were no important between-group differences in organ function damage, including acute liver injury (47 [ 15 however, this difference was not significant (P = 0.1316) (Table 3) (Fig. 3 ). To our knowledge, this report is the first case series to study the effects of sleep quality on the recovery from lymphopenia, deterioration based on an increased NLR, and clinical outcomes in hospitalized patients with COVID-19. Among the 135 patients included in this study, 44.4% of patients reported at least two weeks of good-sleep, and 55.6% patients reported at least two weeks of poor-sleep within three weeks after hospital admission. There were no significant between-group differences regarding demographic and baseline characteristics, as well as laboratory parameters upon admission and in-hospital treatment. Also, no significant differences between the good-sleep group and poor-sleep groups were detected regarding ALC and its recovery rate, as well as NLR on day 7 after hospital admission, indicating an equivalent immune function and its recovery rate between the two groups during the early In patients with COVID-19 with poor-sleep, the most important etiological causes of poorsleep were environmental and psychosocial factors, which accounted for 85.3% and 60.0%, respectively. Physical discomfort caused by illness was another major factor that contributed to poor-sleep during hospitalization in patients with COVID-19. These factors are also the major causal factors of sleep disturbance in ICU patients and could negatively affect recovery from critical illness (Delaney et al., 2015; Devlin et al., 2018; Friese, 2008; Kamdar et al., 2012; Pulak and Jensen, 2016 As a retrospective study, there were no objective tools for sleep assessment in patients with COVID-19. The RCSQ is empirically valid and the most widely used subjective survey instrument for assessing the quality of ICU patients' sleep (Nagatomo et al., 2020; Richards et al., 2000; Simons et al., 2018) . In a clinical study of 70 ICU patients, the RCSQ was validated against polysomnography (PSG) (Richards et al., 2000) , which is considered the gold standard method for evaluating sleep. We chose the RCSQ for assessing the sleep quality of patients with COVID-19 in non-ICU wards, since the frequent shifting of duty during ward-rounds, and the isolated environment without family member' companion in non-ICU ward for patients with COVID-19, are similar to that in the ICU wards for patients who are recovering from critical illness. Since not all patients were able to accurately recollect and assess their daily sleep quality during their hospitalization, we broadened the application scope of the RCSQ and only assessed the overall sleep quality within the first week, second week, and third week after hospital admission. In order to minimize different forms of bias, including recollection and response bias, patients with COVID-19 who were unsure of their sleep quality were excluded from the study. We also lowered the upper limit of the RCSQ score that defines poor-sleep quality (≤ 50) to minimize bias, while the cut-off point differentiating good and poor sleep was 70/100 in previous studies (Mannion et al., 2019; McKinley et al., 2013) . Patients with at least two RCSQ scores of 50-70 were also excluded. After assessment with the RCSQ, overall sleep quality was further confirmed using the Chinese version of the PSQI, which has been shown to be reliable and valid for the 20 Chinese population (Liu et al., 1996) . The PSQI could discriminate between poor and good sleep quality over the preceding 30-days and has been widely used in clinical and non-clinical settings (Mollayeva et al., 2016) . In our study, we used both the RCSQ and the PSQI to better reflect the subjective sleep quality of patients with COVID-19 during hospitalization. Furthermore, patients were excluded in cases of inconsistency between the RCSQ and PSQI scores. In addition, after patients' self-reported sleep assessment, we further checked patients' overall sleep quality by asking their hospital roommates, as well as the doctors and nurses responsible for their treatment. There were some notable limitations in our study. First, a few cases had incomplete documentation of the laboratory parameters at each specific time point, due to lack of necessity for continuous daily tests. Second, it was a single-center retrospective study with a small sample size. Future prospective studies with large patient cohorts are needed to validate the results. Third, although multiple criteria for grouping based on the RCSQ and the PSQI was strictly defined in this study, there could still be recollection and response bias. Therefore, objective sleep monitoring is needed in future studies. Poor-sleep quality in patients with COVID-19 was associated with a slow recovery from lymphopenia, an increased risk of becoming critically ill and requiring ICU care, and After publication, the data supporting the findings of this study can be provided by the corresponding author upon reasonable request. Participant data without names and identifiers can be provided by the corresponding author and the Wuhan Union Hospital after approval. The research team will provide an email address for communication purposes once approval is obtained regarding sharing the data with others. The proposal with detailed description of the study objectives and statistical analysis plan will be needed for evaluation of the purpose for the data request. Additional materials may also be required during the process of evaluation. The authors declare no competing interest. This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors. Malignancy 13 (9.6) 4 (6.7) Chronic respiratory disease 6 (4.4) 1 (1.7) Gastrointestinal disease 4 (3.0) 1 (1.7) Urologic diseases 2 (1.5) 0 (0) Onset of symptom to hospital admission, median (IQR) , days 11.0 (9.0-13.5) 11.0 (9.0-15.0) 11 Signs and symptoms at disease onset: Median ( Creatine kinase-MB ≥ 6.6, ng/mL < 6.6 0 (0) 0 (0) P < 0.05 was considered statistically significant. 42 †Data were missing for the measurement of activated partial thromboplastin time, prothrombin time, or D-dimer in five patients (8.3%), five patients (8.3%), and 10 patients (16.6%) in the good-sleep group, and six patients (8.0%), six patients (8.0%), and 10 patients (13.3%) in the poor-sleep group, respectively. ‡Data regarding creatine kinase were missing for seven patients (11.7%) in the good-sleep group, and 11 patients (14.7%) in the poor-sleep group. The predictors of 3-and 30-day mortality in 660 MERS-CoV patients The Sleep-Immune Crosstalk in Health and Disease Sleep habits and susceptibility to the common cold Sleeping on a problem: the impact of sleep disturbance on intensive care patients -a clinical review Clinical Practice Guidelines for the Prevention and Management of Pain, Agitation/Sedation, Delirium, Immobility, and Sleep Disruption in Adult Patients in the ICU Epidemiological determinants of spread of causal agent of severe acute respiratory syndrome in Hong Kong Short natural sleep is associated with higher T cell and lower NK cell activities Sleep and recovery from critical illness and injury: a review of theory, current practice, and future directions Miller Fisher Syndrome and polyneuritis cranialis in COVID-19 Immediate psychological distress in quarantined patients with COVID-19 and its association with peripheral inflammation: a mixed-method study Elevated inflammatory markers in response to prolonged sleep restriction are associated with increased pain experience in healthy volunteers Perfect timing: circadian rhythms, sleep, and immunityan NIH workshop summary Sleep apnoea patients have higher mortality when confronting sepsis SARS-CoV-2 Detected in Cerebrospinal Fluid by PCR in a Case of COVID-19 Encephalitis Why sleep is important for health: a psychoneuroimmunology perspective Sleep deprivation in critical illness: its role in physical and psychological recovery National Health and Family Planning Commission of China (NHPFC), 2020. New coronavirus pneumonia prevention and control program KDIGO clinical practice guideline for acute kidney injury Neutrophil-to-lymphocyte ratio and lymphocyte-to-C-reactive protein ratio in patients with severe coronavirus disease 2019 (COVID-19): A metaanalysis Subjective neurological symptoms frequently occur in patients with SARS-CoV2 infection Reliability and validity of the Pittsburgh sleep quality index Neutrophil-to-lymphocyte ratio as an independent risk factor for mortality in hospitalized patients with COVID-19 Shift Work and Respiratory Infections in Health-Care Workers Sleep Disturbance in Older Patients in the 28 Emergency Department: Prevalence, Predictors and Associated Outcomes Sleep and psychological health during early recovery from critical illness: an observational study The Pittsburgh sleep quality index as a screening tool for sleep dysfunction in clinical and non-clinical samples: A systematic review and meta-analysis An Official American Thoracic Society Statement: The Importance of Healthy Sleep. Recommendations and Future Priorities Validity of an under-mattress sensor for objective sleep measurement in critically ill patients: a prospective observational study Large-Vessel Stroke as a Presenting Feature of Covid-19 in the Young A prospective 29 study of sleep duration and pneumonia risk in women Behaviorally Assessed Sleep and Susceptibility to the Common Cold Sleep in the Intensive Care Unit: A Review Measurement of sleep in critically ill patients Noise in the intensive care unit and its influence on sleep quality: a multicenter observational study in Dutch intensive care units Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study Guillain-Barre Syndrome Associated with SARS-CoV-2 Adverse effects of modest sleep restriction on sleepiness, performance, and inflammatory cytokines Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study Current status of potential therapeutic candidates for the COVID-19 crisis Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study Lactate dehydrogenase We thank all the patients and their families, as well as the doctors in charge and nurses, involved in the study.